FDA Adverse Event Injury Summary report: N

PROMUS ELEMENT¿ PLUS

MDR report key: 3102351 · Received May 9, 2013

Report

Report Number
2134265-2013-03099
Event Type
Injury
Date Received
May 9, 2013
Date of Event
March 8, 2013
Report Date
April 12, 2013
Manufacturer
BOSTON SCIENTIFIC - GALWAY
Product Code
NIQ
PMA / PMN Number
P110010
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

PATIENT IDENTIFIER: (B)(6). DEVICE IS COMBINATION PRODUCT. DEVICE EVALUATED BY MFR: IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE, A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4).

Description of Event or Problem · 1

(B)(6) CLINICAL STUDY. IT WAS REPORTED THAT DURING A STENTING TREATMENT PROCEDURE, SIDE BRANCH STENOSIS INCREASED. IN (B)(6) 2013, THE PATIENT PRESENTED WITH UNSTABLE ANGINA (BRAUNWALD CLASSIFICATION CLASSIFICATION-IIB) AND WAS REFERRED FOR CARDIAC CATHETERIZATION. THE 60% STENOSED, 32 X 2.75MM TARGET LESION WAS LOCATED IN THE MID LEFT ANTERIOR DESCENDING ARTERY (LAD). THE TARGET LESION WAS TREATED WITH PRE-DILATATION, PLACEMENT OF A 3.00 X 38 MM STUDY STENT AND POST-DILATATION WITH 0% RESIDUAL STENOSIS. THE PATIENT WAS DISCHARGED THE NEXT DAY ON DUAL ANTIPLATELET THERAPY. BASELINE CORE LAB ANGIOGRAPHY REVEALED 0% SIDE BRANCH STENOSIS IN THE 2ND DIAGONAL. POST PROCEDURE ANGIOGRAPHY REVEALED 70% 'BRANCH PERCENT STENOSIS' IN THE 2ND DIAGONAL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
202959 PROMUS ELEMENT¿ PLUS STENT, CORONARY, DRUG-ELUTING NIQ BOSTON SCIENTIFIC - GALWAY H7493911438300 15347138

Patients

Seq Age Sex Outcome Treatment
1 51 YR Other